Highly effective photothermal chemotherapy with pH-responsive polymer-coated drug-loaded melanin-like nanoparticles

• Main Authors: Zhang C, Zhao X, Guo S, Lin T, Guo H
• Format: Article
• Language: English
• Published: Dove Medical Press 2017-03-01
• Series: International Journal of Nanomedicine
• Subjects: prostate cancer; nanoparticles; photothermal therapy; dopamine; drug delivery
• Online Access: https://www.dovepress.com/highly-effective-photothermal-chemotherapy-with-ph-responsive-polymer--peer-reviewed-article-IJN

Chengwei Zhang,1 Xiaozhi Zhao,1 Suhan Guo,2 Tingsheng Lin,1 Hongqian Guo1 1Department of Urology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, 2School of Public Health, Nanjing Medical University, Nanjing, People’s Republic of China Abstract: Dopamine is a neurotransmitter commonly used in clinical treatment. Polydopamine (PDA) has excellent histocompatibility and biosafety and can efficiently convert near-infrared reflection (NIR) to thermal energy. In this study, PDA was used as a promising carrier, and pH-responsive polymer-coated drug-loaded PDA nanoparticles (NPs; doxorubicin@poly(allylamine)-citraconic anhydride [Dox@PAH-cit]/PDA NPs) were developed. As expected, the Dox@PAH-cit/PDA NPs exhibited excellent photothermal efficiency. In addition, at a low pH condition, the loaded Dox was released from the NPs due to the amide hydrolysis of PAH-cit. Upon NIR exposure (808 nm), the temperature of the NP solution rapidly increases to kill tumor cells. Compared with unbound chemotherapy drugs, the NPs have a stronger cell uptake ability. In vivo, the PDA NPs were able to efficiently accumulate at the tumor location. After intravenous administration and NIR exposure, tumor growth was significantly inhibited. In summary, the present investigation demonstrated that the Dox@PAH-cit/PDA NPs presented highly effective photothermal chemotherapy for prostate cancer. Keywords: prostate cancer, photothermal therapy, near-infrared reflection, dopamine, PAH-cit, drug delivery